Specialty Overview

Best Hospitals for Crohn's Disease Treatment in Delhi NCR, India

35 surgical gastroenterology hospitals in our India network are listed in Delhi NCR, accredited by JCI, NABH, NABL, ISO, with 17,362 beds combined.

35
Hospitals Listed
1
City
4.5
Avg. Rating
4
Accreditation Types
The Short Answer

This page lists the surgical gastroenterology hospitals in our directory offering Crohn's Disease Treatment in Delhi NCR, India, including Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute and others. Each listing links through to the hospital's full profile page.

Ask us about crohn's disease treatment in Delhi NCR, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 35 accredited hospitals for Surgical Gastroenterology in Delhi NCR, India

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering crohn's disease treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviewsAccredited by JCI, NABH1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering crohn's disease treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering crohn's disease treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering crohn's disease treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Max Super Specialty Hospital

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
CardiacLiver Transplant
Accredited by JCI, NABH

Patients considering crohn's disease treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
All India Institute of Medical Sciences (AIIMS)

🇮🇳 All India Institute of Medical Sciences (AIIMS)

New Delhi, India 4.7 (3500 reviews) 2,400 beds
Why consider this hospital?
4.7/5 rating from 3500 reviewsAccredited by NABH2,400 beds
Specialties & Accreditation
Multi-specialtyResearch
Accredited by NABH

Patients considering crohn's disease treatment can be cared for by All India Institute of Medical Sciences (AIIMS)'s care team in New Delhi, India, from initial consultation through recovery. All India Institute of Medical Sciences (AIIMS), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.7/5
Rating
1956
Established
2,400
Beds
New Delhi, India
Location
CK Birla Hospital

🇮🇳 CK Birla Hospital

Gurugram, Haryana, India 4.7 (162 reviews) 90 beds
Why consider this hospital?
4.7/5 rating from 162 reviewsAccredited by NABH90 beds
Specialties & Accreditation
Obstetrics & GynecologyOrthopedicsCardiac SciencesOncologyPediatrics
Accredited by NABH

Patients considering crohn's disease treatment can be cared for by CK Birla Hospital's care team in Gurugram, Haryana, India, from initial consultation through recovery. CK Birla Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.7/5
Rating
2017
Established
90
Beds
Gurugram, Haryana, India
Location
Centre for Sight

🇮🇳 Centre for Sight

Safdarjung Enclave, New Delhi, India 4.7 (181 reviews) 30 beds
Why consider this hospital?
4.7/5 rating from 181 reviewsAccredited by NABH30 beds
Specialties & Accreditation
LASIK SurgeryRetina SurgeryCataract SurgeryGlaucomaCornea Transplant
Accredited by NABH

Patients considering crohn's disease treatment can be cared for by Centre for Sight's care team in Safdarjung Enclave, New Delhi, India, from initial consultation through recovery. Centre for Sight, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.7/5
Rating
1996
Established
30
Beds
Safdarjung Enclave, New Delhi, India
Location
Max Super Specialty Hospital, Gurgaon

🇮🇳 Max Super Specialty Hospital, Gurgaon

Gurgaon, India 4.6 (95 reviews) 104 beds
Why consider this hospital?
4.6/5 rating from 95 reviewsAccredited by NABH, JCI104 beds
Specialties & Accreditation
Cardiac SciencesOncologyOrthopedicsNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering crohn's disease treatment can be cared for by Max Super Specialty Hospital, Gurgaon's care team in Gurgaon, India, from initial consultation through recovery. Max Super Specialty Hospital, Gurgaon, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.6/5
Rating
2007
Established
104
Beds
Gurgaon, India
Location
Max Super Speciality Hospital, Patparganj

🇮🇳 Max Super Speciality Hospital, Patparganj

Patparganj, New Delhi, India 4.6 (97 reviews) 400 beds
Why consider this hospital?
4.6/5 rating from 97 reviewsAccredited by NABH, JCI400 beds
Specialties & Accreditation
Cardiac SciencesOncologyOrthopedicsNeurosciencesTransplant
Accredited by NABH, JCI

Patients considering crohn's disease treatment can be cared for by Max Super Speciality Hospital, Patparganj's care team in Patparganj, New Delhi, India, from initial consultation through recovery. Max Super Speciality Hospital, Patparganj, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing crohn's disease treatment.

4.6/5
Rating
2005
Established
400
Beds
Patparganj, New Delhi, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Surgical Gastroenterology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Crohn's Disease Treatment in Delhi NCR, India?

Choosing the right hospital for crohn's disease treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include surgical gastroenterology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Crohn's Disease Treatment

Crohn's disease is a chronic, relapsing inflammatory bowel disease (IBD) requiring lifelong, individualized management ranging from advanced biologic therapies and small-molecule immunomodulators to precision laparoscopic or robotic-assisted intestinal surgery.

5–14 days (medical flare management: 5–7 days; elective bowel resection: 7–14 days)
Hospital Stay
2–6 weeks (biologic infusion/medical management: 2–3 weeks; open or laparoscopic bowel surgery: 4–6 weeks)
Total Stay in Country (Fit-to-Fly)
70–85% sustained clinical remission with biologic therapy; 90–95% short-term surgical success for resection
Success Rate

Clinical Overview

  • Crohn's disease is a transmural, granulomatous inflammatory bowel disease that can affect any segment of the gastrointestinal tract from the mouth to the perianal region, most commonly involving the terminal ileum and proximal colon.
  • Unlike ulcerative colitis, which is confined to the colonic mucosa, Crohn's inflammation penetrates all layers of the bowel wall, predisposing patients to fibrotic strictures, internal fistulae, intra-abdominal abscesses, and perianal septic complications.
  • Disease behavior is classified using the Montreal Classification into inflammatory (B1), stricturing (B2), and penetrating (B3) phenotypes, with perianal disease designated separately (p).
Full details →

Who is a Candidate?

  • ELIGIBLE PATIENTS:
  • Adults and adolescents (age ≥ 6 years under pediatric protocols) with confirmed Crohn's disease diagnosis based on endoscopic, histopathological, and cross-sectional imaging criteria
  • Patients with moderate-to-severe active disease defined by CDAI ≥ 220, HBI ≥ 8, or elevated fecal calprotectin (> 250 µg/g) with concurrent mucosal inflammation on endoscopy
  • Patients failing or intolerant to conventional therapy (corticosteroids, azathioprine, 6-MP, methotrexate) who are candidates for biologic or small-molecule (JAK inhibitor: upadacitinib) induction
  • +26 more

Treatment Options & Approaches

  • MEDICAL (NON-SURGICAL) THERAPIES:

Recovery

  • PHASE 1 — PRE-ARRIVAL PREPARATION (4–6 weeks before travel):

Risks to be aware of

  • Crohn's disease treatment carries procedure-specific and disease-specific risks that must be transparently communicated to international patients.
  • For biologic therapy, the primary risks include serious infections (bacterial, viral reactivation of TB or hepatitis B, opportunistic fungal infections such as Pneumocystis jirovecii pneumonia in patients on triple immunosuppression), infusion-related or injection-site reactions (anaphylaxis incidence < 1% with infliximab), and a statistically elevated but absolute-risk-small increase in lymphoma (primarily hepatosplenic T-cell lymphoma with prolonged thiopurine use in young males) and non-melanoma skin cancer.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, end-to-end coordination service for international Crohn's disease patients traveling to India or the UAE, removing the logistical burden from patients managing a complex chronic illness.

Common questions about Crohn's Disease Treatment

What is the cost of Crohn's Disease Treatment in India versus the UAE?
The total cost of Crohn's disease treatment depends significantly on the modality required. For biologic therapy induction (e.g., infliximab infusion at weeks 0, 2, and 6 with hospitalization and monitoring), costs in India range from approximately USD 3,500 to USD 8,000 for the initial three-infusion induction cycle including diagnostics and hospital stay, compared to USD 7,000 to USD 15,000 for the equivalent protocol in Dubai or Abu Dhabi. For surgical intervention — such as laparoscopic ileocecal resection with pre-operative workup, operating theatre, 7–10 days of hospitalization, anesthesia, pathology, and standard post-operative medications — the all-inclusive cost in India ranges from USD 6,000 to USD 18,000 depending on surgical complexity, hospital tier (NABH vs. JCI), and city. In the UAE, equivalent surgical packages range from USD 14,000 to USD 35,000. Complex perianal Crohn's surgery (VAAFT, seton, advancement flap) adds USD 1,500–USD 4,000 to surgical estimates in India and USD 3,000–USD 8,000 in the UAE. India is typically 50–65% less expensive than the UAE for the same standard of care, and both destinations represent substantial savings versus Western Europe (USD 40,000–USD 80,000) or the United States (USD 60,000–USD 150,000+ for major bowel resection). Biologic drug costs (adalimumab, ustekinumab, vedolizumab) are invoiced separately and vary by agent; Indian biosimilar availability significantly reduces ongoing maintenance therapy costs. GAF Healthcare provides a fully itemized cost estimate upon review of patient records, with no hidden fees.
How long do I need to stay in the country before I am fit to fly home?
The minimum required in-country stay before safe international air travel depends on the treatment pathway. For patients undergoing biologic induction therapy (infliximab IV infusion series or ustekinumab weight-based IV induction), the minimum recommended stay is 2–3 weeks: this covers the infusion itself, a 24-hour post-infusion observation period, and a 2-week recovery interval to assess for delayed infusion reactions, early clinical response, and to ensure oral maintenance therapy (azathioprine, self-injectable biologic) is stable and tolerated before the patient boards a long-haul flight. For patients undergoing elective laparoscopic or robotic-assisted bowel resection (e.g., ileocecal resection, segmental colectomy, strictureplasty), the fit-to-fly period is 4–6 weeks post-surgery. This timeline is determined by the need for wound healing confirmation, anastomotic integrity surveillance (clinical and biochemical), stoma stabilization and output predictability (if a diverting ileostomy was formed), and safe tapering of post-operative VTE prophylaxis (LMWH typically continues for 28 days after major abdominal surgery). Air travel during the early post-operative period carries elevated deep vein thrombosis and pulmonary embolism risk in IBD patients, and cabin pressurization may exacerbate abdominal bloating. For flights exceeding 4 hours, even after clearance, GAF Healthcare arranges a fit-to-fly medical certificate, travel compression stockings, and coordinates a pre-flight LMWH dose with your treating team. Patients with stomas are provided with adequate stoma supplies for the journey and a letter for airport security. All fit-to-fly decisions are made by the treating surgeon or gastroenterologist based on individual clinical assessment, not solely on the above timelines.
What is the success rate of Crohn's Disease Treatment?
Success rates in Crohn's disease must be defined by the treatment modality and the specific endpoint measured, as Crohn's is a chronic relapsing condition without a definitive cure. For biologic induction therapy with anti-TNF agents (infliximab or adalimumab), clinical remission rates at 12 months are approximately 38–58% in anti-TNF-naive patients (ACCENT I, CHARM trial data), with corticosteroid-free remission in combination therapy (anti-TNF + thiopurine) approaching 57% at 26 weeks (SONIC trial). Ustekinumab achieves clinical remission in approximately 40–53% at 44 weeks in biologic-naive and anti-TNF-experienced patients respectively (UNIFI extension data). Mucosal healing — the gold-standard T2T endpoint — is achieved in 30–50% of patients after 1 year of optimized biologic therapy with therapeutic drug monitoring. For surgical intervention, short-term success (technically successful resection with primary anastomosis, absence of major complications) is achieved in over 90–95% of cases at high-volume IBD surgical centres. However, Crohn's disease recurs at the surgical site: endoscopic recurrence at the neo-terminal ileum (Rutgeerts score i2–i4) occurs in 65–90% of patients within 12 months of ileocecal resection without post-operative prophylactic biologic therapy. With immediate post-operative biologic reinstitution (infliximab or adalimumab within 4 weeks of surgery), endoscopic recurrence rates at 12 months are reduced to 9–23% (PREVENT trial, POCER trial). The 10-year cumulative surgical re-operation rate is approximately 30–40% overall, highlighting the critical importance of long-term mucosal healing surveillance and proactive biologic optimization. GAF Healthcare partner centres apply standardized post-operative Rutgeerts scoring at 6 months and mandatory biologic prophylaxis protocols to maximize long-term durable remission for international patients.

How GAF Healthcare Assists in Choosing the Best Hospital for Crohn's Disease Treatment in Delhi NCR, India

Discover the Top Hospitals for Crohn's Disease Treatment in Delhi NCR, India

This page lists 35 accredited surgical gastroenterology hospitals in Delhi NCR, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about crohn's disease treatment in Delhi NCR, India

How many surgical gastroenterology hospitals are listed in Delhi NCR, India?
35 hospitals in our Delhi NCR, India directory are currently listed for surgical gastroenterology including Crohn's Disease Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Surgical Gastroenterology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there surgical gastroenterology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL, ISO — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for crohn's disease treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about crohn's disease treatment in Delhi NCR, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for crohn's disease treatment in Delhi NCR, India.

Contact us to report an inaccuracy on this page.